140 related articles for article (PubMed ID: 35341409)
1. Assessing Bone Marrow Activity with [
Yassin MA; Nehmeh SA; Nashwan AJ; Kohla SA; Mohamed SF; Ismail OM; Al Sabbagh A; Soliman DS; Szabados L; Fayad H
Technol Cancer Res Treat; 2022; 21():15330338221086396. PubMed ID: 35341409
[No Abstract] [Full Text] [Related]
2. Assessing Bone Marrow Activity in Patients with Myelofibrosis: Results of a Pilot Study of
Vercellino L; Ouvrier MJ; Barré E; Cassinat B; de Beco V; Dosquet C; Chevret S; Meignin V; Chomienne C; Toubert ME; Merlet P; Kiladjian JJ
J Nucl Med; 2017 Oct; 58(10):1603-1608. PubMed ID: 28360204
[TBL] [Abstract][Full Text] [Related]
3. A study of 18F-FLT positron emission tomography/computed tomography imaging in cases of prefibrotic/early primary myelofibrosis and essential thrombocythemia.
Yassin MA; Nehmeh SA; Nashwan AJ; Kohla SA; Mohamed SF; Ismail OM; Sabbagh AA; Ibrahim F; Soliman DS; Szabados L; Fayad H
Medicine (Baltimore); 2020 Nov; 99(45):e23088. PubMed ID: 33157979
[TBL] [Abstract][Full Text] [Related]
4. [The morphology features of bone marrow in the prefibrotic-early primary myelofibrosis].
Gong XB; Zhang XH; Lu XG; Tang QS; Gao X; Yang J
Zhonghua Xue Ye Xue Za Zhi; 2012 Jan; 33(1):25-30. PubMed ID: 22575188
[TBL] [Abstract][Full Text] [Related]
5. Volumetric splenomegaly in patients with essential thrombocythemia and prefibrotic/early primary myelofibrosis.
Lee MW; Yeon SH; Ryu H; Song IC; Lee HJ; Yun HJ; Kim SY; Lee JE; Shin KS; Jo DY
Int J Hematol; 2021 Jul; 114(1):35-43. PubMed ID: 33704663
[TBL] [Abstract][Full Text] [Related]
6. JAK2(V617F) allele burden discriminates essential thrombocythemia from a subset of prefibrotic-stage primary myelofibrosis.
Hussein K; Bock O; Theophile K; von Neuhoff N; Buhr T; Schlué J; Büsche G; Kreipe H
Exp Hematol; 2009 Oct; 37(10):1186-1193.e7. PubMed ID: 19616600
[TBL] [Abstract][Full Text] [Related]
7. 18F-FLT PET in hematologic disorders: a novel technique to analyze the bone marrow compartment.
Agool A; Schot BW; Jager PL; Vellenga E
J Nucl Med; 2006 Oct; 47(10):1592-8. PubMed ID: 17015893
[TBL] [Abstract][Full Text] [Related]
8. Clinical and molecular features of patients with prefibrotic primary myelofibrosis previously diagnosed as having essential thrombocythemia in Japan.
Edahiro Y; Araki M; Inano T; Ito M; Morishita S; Misawa K; Fukuda Y; Imai M; Ohsaka A; Komatsu N
Eur J Haematol; 2019 Jun; 102(6):516-520. PubMed ID: 30977935
[TBL] [Abstract][Full Text] [Related]
9. Effect of Platinum-Based Chemoradiotherapy on Cellular Proliferation in Bone Marrow and Spleen, Estimated by (18)F-FLT PET/CT in Patients with Locally Advanced Non-Small Cell Lung Cancer.
Leimgruber A; Möller A; Everitt SJ; Chabrot M; Ball DL; Solomon B; MacManus M; Hicks RJ
J Nucl Med; 2014 Jul; 55(7):1075-80. PubMed ID: 24868108
[TBL] [Abstract][Full Text] [Related]
10. Effect of radiotherapy and chemotherapy on bone marrow activity: a 18F-FLT-PET study.
Agool A; Slart RH; Thorp KK; Glaudemans AW; Cobben DC; Been LB; Burlage FR; Elsinga PH; Dierckx RA; Vellenga E; Holter JL
Nucl Med Commun; 2011 Jan; 32(1):17-22. PubMed ID: 21166089
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow histopathology and biological markers as specific clues to the differential diagnosis of essential thrombocythemia, polycythemia vera and prefibrotic or fibrotic agnogenic myeloid metaplasia.
Michiels JJ
Hematol J; 2004; 5(2):93-102. PubMed ID: 15048058
[TBL] [Abstract][Full Text] [Related]
12. Early/prefibrotic primary myelofibrosis in patients who were initially diagnosed with essential thrombocythemia.
Kamiunten A; Shide K; Kameda T; Ito M; Sekine M; Kubuki Y; Hidaka T; Akizuki K; Tahira Y; Toyama T; Kawano N; Marutsuka K; Maeda K; Takeuchi M; Kawano H; Sato S; Ishizaki J; Shimoda H; Yamashita K; Matsuoka H; Shimoda K
Int J Hematol; 2018 Oct; 108(4):411-415. PubMed ID: 29987745
[TBL] [Abstract][Full Text] [Related]
13. Assessment of biological parameters in head and neck cancer based on in vivo distribution of
Cegla P; Kazmierska J; Gwozdz S; Czepczynski R; Malicki J; Cholewinski W
Tumori; 2020 Feb; 106(1):33-38. PubMed ID: 31446858
[TBL] [Abstract][Full Text] [Related]
14. Essential thrombocythaemia with aggressive megakaryocytosis after myelofibrotic transformation.
Sasaki K; Nannya Y; Nakamura Y; Ichikawa M; Ogawa S; Mitani K
Hematology; 2021 Dec; 26(1):594-600. PubMed ID: 34402416
[TBL] [Abstract][Full Text] [Related]
15. Exploring spatial overlap of high-uptake regions derived from dual tracer positron emission tomography-computer tomography imaging using 18F-fluorodeoxyglucose and 18F-fluorodeoxythymidine in nonsmall cell lung cancer patients: a prospective pilot study.
Liu J; Li C; Hu M; Lu J; Shi X; Xing L; Sun X; Fu Z; Yu J; Meng X
Medicine (Baltimore); 2015 May; 94(17):e678. PubMed ID: 25929896
[TBL] [Abstract][Full Text] [Related]
16.
Tsujikawa T; Tasaki T; Hosono N; Mori T; Makino A; Kiyono Y; Zanotti-Fregonara P; Yamauchi T; Okazawa H
EJNMMI Res; 2019 Feb; 9(1):16. PubMed ID: 30771115
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the diagnostic value of 3-deoxy-3-18F-fluorothymidine and 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the assessment of regional lymph node in thoracic esophageal squamous cell carcinoma: a pilot study.
Han D; Yu J; Zhong X; Fu Z; Mu D; Zhang B; Xu G; Yang W; Zhao S
Dis Esophagus; 2012 Jul; 25(5):416-26. PubMed ID: 21951837
[TBL] [Abstract][Full Text] [Related]
18. The JAK2V617F allele burden and STAT3- and STAT5 phosphorylation in myeloproliferative neoplasms: early prefibrotic myelofibrosis compared with essential thrombocythemia, polycythemia vera and myelofibrosis.
Risum M; Madelung A; Bondo H; Bzorek M; Kristensen MH; Stamp IM; Hasselbalch HC
APMIS; 2011 Aug; 119(8):498-504. PubMed ID: 21749449
[TBL] [Abstract][Full Text] [Related]
19. A pilot study of the diagnostic and prognostic values of FLT-PET/CT for pancreatic cancer: comparison with FDG-PET/CT.
Nakajo M; Kajiya Y; Tani A; Jinguji M; Nakajo M; Nihara T; Fukukura Y; Yoshiura T
Abdom Radiol (NY); 2017 Apr; 42(4):1210-1221. PubMed ID: 27891549
[TBL] [Abstract][Full Text] [Related]
20. Essential thrombocythemia versus early primary myelofibrosis: a multicenter study to validate the WHO classification.
Thiele J; Kvasnicka HM; Müllauer L; Buxhofer-Ausch V; Gisslinger B; Gisslinger H
Blood; 2011 May; 117(21):5710-8. PubMed ID: 21447832
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
